Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,190 INR | -0.03% | -3.79% | -19.04% |
2023 | Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
2023 | Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Sales 2022 | 1.84B 22.01M | Sales 2023 | 2.27B 27.2M | Capitalization | 6.03B 72.18M |
---|---|---|---|---|---|
Net income 2022 | 248M 2.97M | Net income 2023 | 307M 3.68M | EV / Sales 2022 | 2.98 x |
Net Debt 2022 | 32.79M 393K | Net Debt 2023 | 11.68M 140K | EV / Sales 2023 | 2.66 x |
P/E ratio 2022 |
21.9
x | P/E ratio 2023 |
19.6
x | Employees | 315 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.07% |
1 day | -0.03% | ||
1 week | -3.79% | ||
Current month | -1.01% | ||
1 month | -11.68% | ||
3 months | -4.69% | ||
6 months | +0.86% | ||
Current year | -19.04% |
Managers | Title | Age | Since |
---|---|---|---|
Rahul Batra
CEO | Chief Executive Officer | 40 | 14-07-31 |
Varun Batra
CEO | Chief Executive Officer | 39 | 14-07-31 |
Nipun Arora
DFI | Director of Finance/CFO | 40 | 21-03-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Balwant Singh
BRD | Director/Board Member | 54 | 14-07-31 |
Varun Batra
CEO | Chief Executive Officer | 39 | 14-07-31 |
Rahul Batra
CEO | Chief Executive Officer | 40 | 14-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 1,190 | -0.03% | 7,700 |
24-06-03 | 1,191 | -0.97% | 8,500 |
24-05-31 | 1,202 | -4.58% | 15,000 |
24-05-30 | 1,260 | +0.48% | 2,600 |
24-05-29 | 1,254 | +2.01% | 1,400 |
Delayed Quote NSE India S.E., June 04, 2024 at 09:25 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.04% | 138M | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- BETA Stock